CAU Scholar's Space: Oh, Kyung Taek

Detailed Information

Oh, Kyung Taek (오경택)

대학원 (글로벌혁신신약학과)

Research Area

Tel 02-820-5617
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Albumin nanoparticles:8||Tumor targeting:8||cancer:7||Solubility:6||photodynamic therapy:5||photothermal therapy:5||Doxorubicin:5||Exendin4:5||Nanomedicine:5||nanomedicine:5||Type 2 diabetes:4||Glycol chitosan:4||Chlorin e6:4||Photodynamic therapy:4||photodynamic tumor therapy:4||Hyperthermia:4||Albumin:4||Inhalation:4||Nanoparticles:3||polymeric micelle:3||Hyaluronic acid:3||Pulmonary delivery:3||Breast cancer:3||Drug delivery system:3||oral bioavailability:3||pH sensitive:3||Hypoglycemia:3||tumor acidic pH:3||chlorin e6:3||Bioavailability:3||Lung cancer:3||Irinotecan:3||Bioequivalence:2||pHresponsive nanoparticle:2||Globular poly(ethylene glycol):2||cyclic RGD:2||nanocarrier:2||Triblock copolymer:2||Tumor extracellular pH:2||nanoparticles:2||Gold nanoclusters:2||Tumor therapy:2||Albuminbinding:2||Gold nanorods:2||pH sensitive polymer:2||transferrin:2||tumor targeting:2||tumor therapy:2||Enhanced dissolution:2||tumortargeted drug delivery system:2||drug delivery:2||type 2 diabetes:2||pHdependent drug release:2||drug delivery system:2||pHresponsive:2||drug release kinetics:2||PLGA:2||Nanosized:2||drug solubility:2||Antitumor therapy:2||Animal imaging:2||Selfassembly:2||albuminbinding:2||Nanoparticle:2||Photodynamic tumor therapy:2||3Diethylaminopropyl:2||Solid dispersion:2||Chronic obstructive pulmonary disease:2||Cilostazol:2||Photothermal therapy:2||Physicochemical properties:2||Hyaluronidase:2||Liposomes:2||3(Diethylamino)propyl:2||poly(lactidecoglycolide):2||polyelectrolyte:2||Hydrogel:2||Oral bioavailability:2||inhalation:2||MDR:2||4arm PEG:2||porous microspheres:2||Synergism:2||Crystallinity:2||Porous microparticle:2||Porous microparticles:2||Biocompatibility:2||sialic acid:2||Hepatitis C virus (HCV):1||Hepatocellular carcinoma:1||Hoechst 33258:1||Human IgG4:1||Hyaluronated starch nanogels:1||Hyaluronidaseresponsive nanoparticle:1||Hybrid nanoparticles:1||Hydrogels:1||Hydrophobic interaction:1||Hyperspectrum:1||Hyperthermal therapy:1||Hypoxia:1||Hypoxic tumor:1||IFNalpha2b:1||In vivo bioavailability:1||In vivo oral bioavailability:1||Indocyanine green:1||Inhalant formulation:1||Inorganic mesoporous carrier:1||Insoluble drug:1||Interferonalpha (IFNalpha):1||Intranasal:1||Iron oxide:1||Itraconazole:1||Jet milling:1||Lsulpiride:1||LSPR:1||Lactose:1||Light:1||Lipid based nanomedicine:1||Lipophilic drugs:1||Liver targetability:1||Lutein:1||Lysosomal pH:1||Maackia fauriei:1||Magnetic resonance imaging (MRI):1||Membrane emulsification:1||Metastasis:1||Metastatic lung cancers:1||Micelle:1||Microsphere:1||Mixed micellar formulation:1||Molecular Imaging:1||Morphology:1||Multilayered vesicle:1||Multiple dosing:1||Multiple ligands:1||NUFS:1||Nab (R) Technology:1||Nail business:1||Nail reinforced products:1||Nail stratified:1||Nano:1||Nanocomplex:1||Nanoemulsion:1||Nanoplatform:1||Nanoporous sphere/fiber:1||Nanosize:1||Nanosuspension:1||Nanotechnology:1||Nanovehicles:1||Nifedipine:1||Oily drug:1||Oily liquid drug:1||Onychoschizia:1||Ophthalmic drug delivery system:1||Oral absorption:1||Oral drug delivery:1||Oral pharmacokinetics:1||Oxygengeneration:1||Oxygenation:1||PEG:1||PEGPLAPEI:1||PEGPLLPLA:1||PEGbpoly(Lhistidine)bpoly(Llactic acid)bPEG:1||PEGylation:1||PH:1||PHsensitive extracellular vesicles:1||PLAbmPEG:1||PLGA microparticle:1||PLGA nanoparticles:1||PLLAbPEGfolate nanoparticle:1||Paclitaxel:1||Palmitic acid:1||Palmitic acidmodified exendin4:1||Palmitylacylated exendin4:1||Palmitylacylation:1||Pancreatic cancer:1||Peptide/protein drug:1||Phsensitivity:1||Phosphoric acid:1||Photochemo combination therapy:1||Photodynamic:1||Photodynamic therapy (PDT):1||Photosensitive pHjump:1||Photosynthesis:1||Photothermal:1||Photothermal conversion:1||Pluronic:1||Pluronic L121/F127:1||Plutonic:1||Poly (lactidecoglycolide):1||Poly(Laspartic acid) derivative:1||Poly(Laspartic acid) derivative nanogels:1||Poly(Lhistidine):1||Poly(amino acid):1||Poly(gammacyclodextrin):1||Polyelectrolyte:1||Polymer based nanomedicine:1||Polymer therapeutics:1||Polymeric micelle:1||Polypeptide:1||Polysaccharide:1||Polysaccharidic nanogels:1||Poorly watersoluble drug:1||Porous microspheres:1||Prasugrel base:1||Precipitation and crystallisation:1||Protein delivery:1||Protonation:1||Pseudoternary phase diagram:1||Pulmonary fibrosis:1||Pulverisation:1||Quaternary microcapsule:1||Quick gelation:1||Receptordriven cancer targeting:1||Revaprazan:1||Revaprazan hydrochloride:1||SSNEDDS:1||SPIO:1||Selfassembled nanoparticles:1||Selfemulsifying drug delivery system:1||Selfemulsifying solid dispersion:1||Selfnanoemulsifying solid dispersion:1||Shirasu porous glass membrane:1||Solid SEDDS:1||Solid SNEDDS:1||Solid dispersion granules:1||Solid selfnanoemulsifying drug delivery system:1||Solubilization capacity:1||Solventevaporated solid dispersion:1||Solventfree delivery system:1||Solventwetted solid dispersion:1||Stability:1||Stable platform:1||Starchglycol chitosan nanogels:1||Stem Cells:1||Stimuli:1||Stimulusresponsive:1||Supercritical fluid:1||Superparamagnetic iron oxide (SPIO):1||Supramolecular association:1||Surface adsorption:1||Surfaceattached solid dispersion:1||Sustained release tablet:1||Sustainedrelease:1||Synergistic efficacy:1||T2 relaxivity coefficients:1||TNFrelated apoptosisinducing ligand:1||TRAIL:1||Tacrolimus:1||Targeting:1||Tiotropium:1||Topdown process:1||Toxicity:1||Transdermal drug delivery:1||Transforming Growth Factor:1||Triblock copolymer:1||Tumor spheroid:1||Tumor suppression:1||Tumorhoming extracellular vesicles:1||Tumoridentifying polypeptide:1||Volatile solvent:1||Wormlike micelle:1||Zincimidazole interaction:1||acidic tumor targeting:1||active targeting:1||adsorbent:1||albumin nanoparticles:1||albumincoating:1||alendronate:1||amorphous microspheres:1||amphiphiles:1||amphiphilic block copolymer:1||animal imaging:1||anthocyanin:1||antitumor efficacy:1||anticancer drug delivery:1||anticancer drugs:1||anticancer vaccine:1||antiviral:1||apoptosis:1||aqueous microenvironment:1||bark:1||betacyclodextrin:1||binary system:1||bioavailability:1||biological evaluation of dosage forms:1||blending micellar system:1||blending system:1||block copolymer:1||bone metastasis:1||brain tumors:1||burst effect:1||calcium silicate:1||charge conversion:1||chemotherapy:1||chitosan:1||chitosancoating:1||chlorine e6:1||chronic obstructive pulmonary disease:1||circulating tumor cell:1||controlled release:1||controlled and sustainedrelease systems:1||correlation equation:1||crosslinking:1||crystalline microspheres:1||curcumin:1||dendritic cells:1||deposition:1||diffusioncontrolled coated tablet:1||disulfide linkage:1||docetaxel:1||docetaxel release:1||dog boneshaped:1||dosage form design and characterization:1||double reverse thermosensitive nanocarrier:1||doxorubicin:1||doxorubicinresistant cancer:1||drug delivery systems:1||drug release rate:1||endosomal escape:1||endosomolytic activity:1||exendin4:1||extracellular vesicles:1||fast emulsifying tablet:1||fluticasone propionate:1||gasforming:1||gasforming micelle:1||gastroretention tablets:1||gelatin:1||gene delivery:1||globular poly(ethylene glycol):1||gold nanoparticle:1||gold nanoparticles:1||gold nanorod:1||gold nanorods:1||hyaluronate dot:1||hyaluronate nanogels:1||hyaluronated fullerene:1||hyaluronidase:1||hydroxypropyl methylcellulose:1||hypoxia:1||ibuprofen:1||imaging agents:1||inclusion compound:1||indocyanine green:1||iodomethyltriphenylphosphonium (IMTP):1||isothiocyanatoLlysine:1||lactose:1||lectin:1||legume:1||light:1||liposomal complex:1||liposome:1||localized surface plasmon resonance:1||lyophilization:1||matrixtype casted film:1||metastatic tumor:1||micelle destabilization:1||micelles:1||mitochondriaselective:1||modulation:1||multidrug resistance:1||multifunctionality:1||multimeric micelles:1||nanopin:1||nanosized drug carrier:1||nanocluster:1||nanoconfinement:1||nanoparticle:1||nanosized:1||near infrared:1||necrosis:1||oncothermia:1||optical imaging:1||oral administration:1||pHResponsive gammacyclodextrin:1||pHResponsive liposome:1||pHResponsive nanogels:1||pHindependent release:1||pHresponsive gammacyclodextrin nanoparticles:1||pHresponsive nanogel:1||pHresponsive polymeric micelle:1||pHsensitive:1||pHsensitive chitosan nanofiber:1||pHsensitive cyclodextrin cap:1||pHsensitive flowerlike micelle:1||pHsensitive nanocarrier:1||pHsensitive nanogels:1||pHsensitive polymer:1||pHsensitivity:1||pHtriggered surface charge switching:1||palmitylacylated exendin4:1||particleinparticle:1||pharmaceutics and drug delivery:1||photochemo combination therapy:1||photodynamic chlorin e6:1||photodynamic tumor therpy:1||photoresponsive nanogels:1||photosensitizing agent:1||photosensitizing drug:1||phototherapy:1||photothermal gold nanoparticles:1||pinshaped:1||poly(aspartic acidgraftimidazole):1||poly(betacyclodextrin):1||poly(ethylene glycol):1||poly(ethylene glycol)bpoly(Llactic acid):1||polyelectrolyte ionomer complex:1||polyelectrolytes:1||polymeric coating materials:1||polymeric micelles:1||polymeric nanoparticles:1||polyplex:1||polysaccharides:1||porogen:1||porous microparticles:1||powder formulation:1||proapoptotic peptide:1||pulmonary drug delivery:1||rabies virus:1||reconstitution:1||rectal administration:1||releasecontrolling power:1||revaprazan:1||salmeterol xinafoate:1||sildenafil:1||singlewall carbon nanotube:1||small interference RNA:1||solid selfnanoemulsifying drug delivery system:1||solubility:1||solubilization:1||spraydrying:1||stimulisensitive polymers:1||succinate:1||superporous networks:1||surfacemodified solid dispersion:1||sustained release:1||swelling:1||synergistic tumor therapy:1||targeting:1||tetrablock copolymer:1||tetrakis(4carboxyphenyl)porphyrin:1||tiotropium:1||tolllike receptor 4 signaling:1||topotecan:1||toxicity:1||triblock copolymer:1||tumor treatment:1||tumortargeting ligand:1||unchanged crystalline:1||upconverting nanoparticles:1||urokinasetype plasminogen activator:1||vitamin C:1||1Palmitoyl2linoleoyl3acetylracglycerol:1||watersoluble nanoparticle:1||1palmitoyl2linoleoyl3acetylracglycerol:1||2,3Dimethyl maleic aicd:1||2,3dimethylmaleic acid:1||3(diethylamino)propylamine:1||3Diethylamino propyl:1||3Diethylaminopropyl (DEAP):1||3diethylaminopropyl:1||4(4(1hydroxyethyl)2methoxy5nitrophenoxy)butyric acid (HMNB):1||Acidlabile bond:1||Acidic pH:1||Acidosis:1||Adamantane:1||Administered drug dose:1||Albumin binding:1||Anthocyanin:1||Antitumour efficacy:1||Anticancer:1||Antitumor activity:1||Antitumor drug delivery:1||Antitumor efficacy:1||Apoptosis:1||Apotransferrinstearic acid conjugate:1||Asialoglycoprotein receptor:1||Betacarotene:1||Binary system:1||Biodegradable implant:1||Bleomycininduced fibrosis model:1||Block copolymer:1||Bortezomib:1||Bovine serum albumin:1||Brain delivery:1||Burst effect:1||CD44 receptor:1||Cancer:1||Cancer chemotherapy:1||Cancer therapy:1||Celastrol:1||Chargeswitched nanocomplex:1||Chemotherapy:1||Chitosan hydrogels:1||Chlorella:1||Circadian zeitgeber:1||Combination:1||Combined antitumor effect:1||Controlled release tablet:1||Cyclic arginineglycineaspartic acid (cRGD) peptide:1||Cytokine:1||D(KLAKLAK)(2) proapoptotic peptide:1||Dalphatocopheryl polyethylene glycol 1000:1||Dabigatran etexilate:1||Dabigatran etexilate hemisuccinate:1||Decanoic acid:1||Diethylaminopropyl group:1||Docetaxel:1||Dosing times:1||Double peak phenomena:1||Doublereversible thermogel:1||Drug delivery:1||Drug delivery systems:1||Drug trap mesh:1||Dry powder inhaler:1||EDS imaging:1||Electrospinning:1||Emulsion droplet size:1||Emulsion morphology:1||Endosomal escape:1||Environmentally sensitive:1||Erectile Dysfunction:1||Extracellular matrix:1||FESEM:1||FRET:1||Fattigationplatform:1||Fatty acid modification:1||Fe3O4:1||Folic acid:1||Food components:1||Formulation:1||Fujicalin (R):1||Fullerene conjugates:1||Gelatine microsphere:1||Gemcitabine:1||Gene carrier:1||Genipin:1||Gold nanoparticle:1||Gold nanoshell:1||HM10660A:1||Hemoglobin:1||

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE